Literature DB >> 17619254

Comparison of ELISA with shell vial cell culture method for the detection of human rotavirus in fecal specimens.

Candan Cicek1, Tuba Karatas, Imre Altuglu, Guldane Koturoglu, Zafer Kurugol, Altinay Bilgic.   

Abstract

The aim of the study was to compare an enzyme immunoassay method with shell vial cell culture method for detection of rotavirus in fecal specimens. In addition, the correlation between laboratory results and clinical scores of patients with gastroenteritis was evaluated. A total of 219 fecal specimens from children (ages 3 weeks to 5 years) with acute gastroenteritis submitted to pediatric emergency room were evaluated by both ELISA and shell vial cell culture. A Vesikari score was used for assessing the severity of the illness. Among 219 stool samples tested, 107 (48.9%) were determined to be positive. Two specimens were positive by shell vial cell culture method while they were ELISA negative. According to these results the calculated sensitivity, specificity, PPV, and NPV of ELISA were 98.1%, 100%, 100%, and 98.2%, respectively. The mean severity score for the 107 episodes of rotavirus diarrhoea was 11.0 +/- 3.6 compared to 4.5 +/- 1.9 for the 112 episodes of non-rotavirus diarrhea in the same population. Our study indicates that ELISA, which is easier to perform, faster and cheaper than cell culture methods may be suitable for routine diagnosis of rotavirus infections. The severity of rotavirus positive gastroenteritis was significantly higher than that of rotavirus negative patients.

Entities:  

Mesh:

Year:  2007        PMID: 17619254

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  2 in total

1.  Randomised controlled trial of Lactobacillus rhamnosus (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol.

Authors:  David Schnadower; Phillip I Tarr; T Charles Casper; Marc H Gorelick; Michael J Dean; Karen J O'Connell; Prashant Mahajan; Thomas H Chun; Seema R Bhatt; Cindy G Roskind; Elizabeth C Powell; Alexander J Rogers; Cheryl Vance; Robert E Sapien; Feng Gao; Stephen B Freedman
Journal:  BMJ Open       Date:  2017-09-24       Impact factor: 2.692

2.  Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial.

Authors:  Stephen B Freedman; Sarah Williamson-Urquhart; Suzanne Schuh; Philip M Sherman; Ken J Farion; Serge Gouin; Andrew R Willan; Ron Goeree; David W Johnson; Karen Black; David Schnadower; Marc H Gorelick
Journal:  Trials       Date:  2014-05-14       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.